Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Roivant Sciences Ltd
(NQ:
ROIV
)
11.88
+0.20 (+1.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,831,066
Open
11.77
Bid (Size)
11.88 (17)
Ask (Size)
11.89 (114)
Prev. Close
11.68
Today's Range
11.61 - 11.89
52wk Range
8.245 - 13.24
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
August 08, 2024
From
Roivant Sciences
Via
GlobeNewswire
Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024
July 25, 2024
From
Roivant Sciences
Via
GlobeNewswire
Performance
YTD
+4.67%
+4.67%
1 Month
+10.61%
+10.61%
3 Month
+9.70%
+9.70%
6 Month
+1.54%
+1.54%
1 Year
+6.64%
+6.64%
More News
Read More
Evaluating Roivant Sciences: Insights From 6 Financial Analysts
June 18, 2024
Via
Benzinga
The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
May 31, 2024
Via
Benzinga
ROIV Stock Earnings: Roivant Sciences Beats EPS, Misses Revenue for Q4 2024
May 30, 2024
Via
InvestorPlace
Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know
April 22, 2024
Via
Benzinga
Where Roivant Sciences Stands With Analysts
March 25, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Roivant Sciences
February 14, 2024
Via
Benzinga
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
May 30, 2024
From
Roivant Sciences
Via
GlobeNewswire
Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock: What's Going On?
May 22, 2024
Via
Benzinga
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
May 16, 2024
From
Roivant Sciences
Via
GlobeNewswire
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
May 07, 2024
Via
InvestorPlace
Roivant Sciences Earnings Preview
February 12, 2024
Via
Benzinga
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
May 01, 2024
Via
InvestorPlace
Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study
April 02, 2024
Via
Benzinga
Roivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease Study
April 02, 2024
Via
Investor's Business Daily
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
April 02, 2024
From
Roivant Sciences
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
Via
Benzinga
Solar Stocks Rally, Led By Sunrun, SolarEdge, Enphase
March 27, 2024
Via
Investor's Business Daily
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via
Benzinga
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
February 13, 2024
From
Roivant Sciences
Via
GlobeNewswire
Earnings Scheduled For February 13, 2024
February 13, 2024
Via
Benzinga
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024
January 30, 2024
From
Roivant Sciences
Via
GlobeNewswire
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
January 12, 2024
Via
Investor's Business Daily
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.